LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Relative Growth Rate After Treatment
SK-BR-3 GSK1059615
10.0
uM
LJP5
1
E01
72
hr
1401 504 4223 0.1193 -0.3181
SK-BR-3 GSK1059615
10.0
uM
LJP5
2
E01
72
hr
1401 870 4223 0.2060 -0.1884
SK-BR-3 GSK1059615
10.0
uM
LJP5
3
E01
72
hr
1401 1209 4223 0.2863 -0.0682
SK-BR-3 GSK1059615
10.0
uM
LJP6
1
C01
72
hr
1401 489 4223 0.1158 -0.3234
SK-BR-3 GSK1059615
10.0
uM
LJP6
2
C01
72
hr
1401 808 4223 0.1913 -0.2104
SK-BR-3 GSK1059615
10.0
uM
LJP6
3
C01
72
hr
1401 785 4223 0.1859 -0.2185
SK-BR-3 GSK1904529A
10.0
uM
LJP6
1
H19
72
hr
1401 4240 4223 1.0040 1.0060
SK-BR-3 GSK1904529A
10.0
uM
LJP6
2
H19
72
hr
1401 4401 4223 1.0421 1.0631
SK-BR-3 GSK1904529A
10.0
uM
LJP6
3
H19
72
hr
1401 4258 4223 1.0083 1.0124
SK-BR-3 Omipalisib
10.0
uM
LJP6
1
N01
72
hr
1401 808 4223 0.1913 -0.2104
SK-BR-3 Omipalisib
10.0
uM
LJP6
2
N01
72
hr
1401 848 4223 0.2008 -0.1962
SK-BR-3 Omipalisib
10.0
uM
LJP6
3
N01
72
hr
1401 909 4223 0.2153 -0.1746
SK-BR-3 GSK 690693
10.0
uM
LJP5
1
F19
72
hr
1401 3164 4223 0.7492 0.6246
SK-BR-3 GSK 690693
10.0
uM
LJP5
2
F19
72
hr
1401 2759 4223 0.6533 0.4811
SK-BR-3 GSK 690693
10.0
uM
LJP5
3
F19
72
hr
1401 3101 4223 0.7343 0.6023
SK-BR-3 GW843682X
10.0
uM
LJP6
1
B13
72
hr
1401 1506 4223 0.3566 0.0370
SK-BR-3 GW843682X
10.0
uM
LJP6
2
B13
72
hr
1401 1796 4223 0.4253 0.1398
SK-BR-3 GW843682X
10.0
uM
LJP6
3
B13
72
hr
1401 1900 4223 0.4499 0.1767
SK-BR-3 HG-5-113-01
10.0
uM
LJP5
1
B07
72
hr
1401 1152 4223 0.2728 -0.0884
SK-BR-3 HG-5-113-01
10.0
uM
LJP5
2
B07
72
hr
1401 1331 4223 0.3152 -0.0250
SK-BR-3 HG-5-113-01
10.0
uM
LJP5
3
B07
72
hr
1401 1326 4223 0.3140 -0.0268
SK-BR-3 HG-5-88-01
10.0
uM
LJP6
1
A19
72
hr
1401 2149 4223 0.5089 0.2649
SK-BR-3 HG-5-88-01
10.0
uM
LJP6
2
A19
72
hr
1401 2021 4223 0.4786 0.2196
SK-BR-3 HG-5-88-01
10.0
uM
LJP6
3
A19
72
hr
1401 2130 4223 0.5044 0.2582
SK-BR-3 Imatinib
10.0
uM
LJP6
1
N13
72
hr
1401 4120 4223 0.9756 0.9635